Procter & Gamble (NYSE:PG – Get Free Report) posted its earnings results on Wednesday. The company reported $1.88 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.01), Zacks reports. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble updated its FY 2025 guidance to 6.910-7.050 EPS.
Procter & Gamble Trading Up 0.4 %
NYSE PG opened at $161.77 on Wednesday. Procter & Gamble has a 12 month low of $146.28 and a 12 month high of $180.43. The company has a market capitalization of $380.96 billion, a price-to-earnings ratio of 27.89, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm’s fifty day moving average price is $169.09 and its 200 day moving average price is $169.44.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.49%. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Insider Transactions at Procter & Gamble
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. JPMorgan Chase & Co. reduced their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. Evercore ISI increased their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Stifel Nicolaus decreased their price objective on shares of Procter & Gamble from $167.00 to $161.00 and set a “hold” rating on the stock in a report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.65.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- The How and Why of Investing in Gold Stocks
- Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
- How to Effectively Use the MarketBeat Ratings Screener
- Super Micro Computer: Turning Risk Into Reward at the Crossroads
- Health Care Stocks Explained: Why You Might Want to Invest
- After a Reset Year, Is Moderna Stock Poised for a Comeback?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.